Related Experiment Video
Updated: Aug 7, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Severe hepatotoxicity after therapeutic doses of acetaminophen
Oswald Moling1, Elena Cairon, Giovanni Rimenti
1Division of Infectious Diseases, Ospedale Generale, Bolzano, Italy. molosw@hotmail.com
Background:
Acetaminophen overdose is a frequent cause of acute liver failure. Controversy exists over the rare association of severe hepatotoxicity or acute liver failure with therapeutic doses of acetaminophen.
Case Summary:
A 45-year-old white man weighing 85 kg with asymptomatic HIV, hepatitis B virus, and hepatitis C virus (HCV) infection presented with signs of severe hepatotoxicity: aspartate aminotransferase (AST), 8,581 IU/L; alanine aminotransferase (ALT), 5,433 IU/L; L-lactate dehydrogenase, 13,641 IU/L; and prothrombin international normalized ratio, 2.15. He reported taking acetaminophen 1,000 mg QID for the previous 4 days and 1,000 mg that morning because of a febrile illness. Immediate administration of continuous IV N-acetylcysteine 150 mg/kg for the first 90 minutes and then 50 mg/kg q4h for the next 3 days was followed by clinical improvement and a rapid decrease in AST and ALT. AST levels decreased from 8,581 to 42 IU/L within 11 days. Several potential risk factors for acetaminophen hepatotoxicity (ie, chronic alcohol, tobacco, and opiate consumption, malnutrition, illness-induced starvation, HIV infection, and HCV infection) were present in this patient.
Conclusions:
This patient with multiple risk factors and severe hepatotoxicity after therapeutic dosage of acetaminophen was successfully treated with N-acetylcysteine.
Insights
Severe liver injury from acetaminophen at therapeutic doses can occur, especially with risk factors. Prompt N-acetylcysteine treatment effectively resolved acetaminophen-induced hepatotoxicity in a patient with multiple comorbidities.
Area of Science:
- Hepatology
- Clinical Toxicology
- Pharmacology
Background:
- Acetaminophen overdose is a common cause of acute liver failure.
- The association between therapeutic acetaminophen doses and severe hepatotoxicity remains controversial.
- Multiple risk factors can increase susceptibility to acetaminophen-induced liver injury.
Observation:
- A patient with HIV, hepatitis B, and hepatitis C presented with severe hepatotoxicity after taking acetaminophen 1,000 mg four times daily for four days.
- The patient exhibited significantly elevated liver enzymes (AST, ALT) and a high prothrombin international normalized ratio.
- Potential risk factors including chronic infections and malnutrition were present.
Findings:
- Continuous intravenous N-acetylcysteine administration led to rapid clinical improvement.
- Liver enzyme levels (AST, ALT) decreased dramatically within 11 days of treatment.
- N-acetylcysteine was effective in treating severe hepatotoxicity in this patient.
Implications:
- This case highlights the potential for severe liver injury even at therapeutic acetaminophen doses in patients with risk factors.
- Early recognition and prompt N-acetylcysteine treatment are crucial for managing acetaminophen-induced hepatotoxicity.
- Further research may clarify the precise mechanisms and risk stratification for acetaminophen hepatotoxicity at therapeutic doses.
Related Concept Videos
Drug Toxicity: Dose-Dependent Reactions
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug toxicity: Drug–Drug Interaction
Drug Toxicity: Overview
